Why Millions Are Switching from CPAP to Oral Appliances in 2026

Something significant is happening in sleep medicine, and the numbers tell the story clearly. The global oral appliance market for sleep-disordered breathing is growing at a compound annual growth rate of approximately 10%, and industry analysts at Grand View Research project the market will exceed $1 billion by 2030. At the same time, CPAP compliance rates remain stubbornly below 50%, a figure that has barely budged despite decades of technological improvements to the machines themselves.

The migration from CPAP to oral appliances is not a fad. It is a market correction driven by a fundamental mismatch between treatment burden and patient tolerance. CPAP works when people use it. The problem is that most people stop using it — and the sleep medicine establishment is finally acknowledging that adherence to treatment matters as much as the theoretical efficacy of the treatment itself.

In 2026, updated guidelines from the American Academy of Sleep Medicine (AASM) now recommend oral appliances as a first-line treatment for mild-to-moderate obstructive sleep apnea, not merely as a fallback when CPAP fails. This represents a meaningful shift in clinical consensus and reflects what patients have been demonstrating with their behavior for years: the best treatment is the one you actually use.

Why CPAP Compliance Remains Below 50%

CPAP — continuous positive airway pressure — is mechanically effective at eliminating airway obstruction. A machine generates a constant stream of pressurized air delivered through a mask that holds the airway open during sleep. When used consistently, CPAP reduces apnea events to near-zero in most patients. The technology works. The compliance problem is not about efficacy — it is about livability.

Research published in the Journal of Clinical Sleep Medicine has identified the primary reasons patients abandon CPAP therapy. Mask discomfort and air leaks top the list, affecting an estimated 50 to 60% of users. The sensation of pressurized air being forced into the airway triggers claustrophobia in a substantial minority of patients. Nasal congestion, dry mouth, skin irritation from mask straps, and aerophagia (swallowing air, leading to bloating and gas) are reported by 30 to 40% of users.

Beyond physical discomfort, CPAP imposes a lifestyle burden that many patients find unsustainable. The machine requires a power source, making travel cumbersome. The noise, while greatly reduced in modern machines, still disturbs some bed partners. The mask creates an intimacy barrier that many couples find psychologically significant. The nightly routine of filling the humidifier, fitting the mask, adjusting straps, and connecting tubing transforms bedtime from a simple act into a medical procedure.

The result is predictable. Studies tracking long-term CPAP usage consistently show that adherence drops sharply after the first three months. By the one-year mark, fewer than half of patients are using their machine for the minimum four hours per night that Medicare defines as compliant use. And four hours is itself a low bar — most adults sleep seven to eight hours, meaning that even “compliant” CPAP users are unprotected for half the night.

The Clinical Case for Oral Appliances

Oral appliances — specifically mandibular advancement devices (MADs) — work by repositioning the lower jaw forward during sleep, which physically opens the oropharyngeal airway and reduces the tissue vibration and collapse that cause snoring and apnea events. The mechanism is fundamentally different from CPAP: instead of forcing the airway open with pressurized air, a MAD structurally repositions the anatomy to prevent collapse in the first place.

The evidence base for oral appliances has strengthened considerably over the past decade. Meta-analyses comparing CPAP and oral appliances for mild-to-moderate OSA show that while CPAP achieves greater reductions in the apnea-hypopnea index (AHI) in controlled settings, oral appliances achieve comparable improvements in patient-reported outcomes: daytime sleepiness, sleep quality, cognitive function, and blood pressure. The reason for this apparent paradox is compliance. A treatment that reduces AHI by 80% but is used 50% of the time delivers less real-world benefit than a treatment that reduces AHI by 60% and is used 90% of the time.

This is precisely what the research shows. Oral appliance compliance rates consistently exceed 75% at one year and remain above 65% at five years — dramatically higher than CPAP compliance at equivalent timepoints. The AASM’s updated guidelines reflect this reality: when you factor in real-world adherence, oral appliances deliver equivalent or superior health outcomes for mild-to-moderate OSA compared to CPAP.

Understanding how mandibular advancement works helps explain why compliance is so much higher. A mouthpiece is silent, portable, requires no power source, does not cover the face, and takes seconds to insert. It does not interfere with intimacy, does not require maintenance beyond basic cleaning, and fits in a pocket for travel. The treatment burden is orders of magnitude lower than CPAP, and lower treatment burden translates directly into higher adherence.

Types of Oral Appliances: Custom vs. OTC

The oral appliance market in 2026 spans a wide range of options, from custom-fabricated devices made by dental sleep specialists to over-the-counter boil-and-bite devices available without a prescription. Understanding the differences is critical for making an informed choice.

Custom dental appliances ($1,500 – $3,000+) are fabricated from dental impressions by a specialist trained in dental sleep medicine. They offer precise fit, adjustable advancement measured in millimeters, and are made from durable medical-grade materials that last three to five years. Insurance may cover part of the cost for diagnosed OSA, though coverage varies widely by plan. The primary barriers are cost, the requirement for multiple dental appointments, and the weeks-long fabrication timeline.

Over-the-counter boil-and-bite devices ($49 – $149) use thermoplastic materials that soften in hot water and mold to your teeth when you bite down. Modern OTC devices like the Snorple mouthpiece have evolved considerably from early-generation one-size-fits-all designs. The best OTC options now offer adjustable advancement, dual-material construction for comfort, and airway channels that allow mouth breathing. At $69, the Snorple mouthpiece costs a fraction of a custom appliance while using the same mandibular advancement mechanism.

The question of expensive versus affordable mouthpieces ultimately comes down to the severity of your condition and your priorities. For primary snoring and mild OSA, an OTC device is a clinically reasonable first step. For moderate-to-severe OSA, a custom appliance offers more precise titration, and for severe OSA, CPAP remains the recommended first-line therapy despite its compliance challenges.

Who Benefits Most from the Switch

Not every CPAP user is a candidate for oral appliance therapy, and it is important to be specific about who benefits most from making the switch.

Primary snorers without diagnosed OSA. If you snore loudly but have never been diagnosed with obstructive sleep apnea — or if a sleep study showed an AHI below 5 — you are the ideal candidate for an OTC oral appliance. CPAP is not indicated for primary snoring, and a mouthpiece addresses the mechanical cause directly. This is the largest underserved group, and an OTC device is the most proportionate response.

Mild-to-moderate OSA patients (AHI 5 – 30). The updated AASM guidelines now position oral appliances as a first-line option alongside CPAP for this group. If you have tried CPAP and abandoned it — or if you are newly diagnosed and want to start with the less invasive option — oral appliance therapy is a clinically supported choice. A direct comparison of CPAP versus mouthpiece therapy shows that real-world outcomes are comparable when compliance is factored in.

CPAP non-compliant patients. If your CPAP machine is collecting dust in the closet, you are not alone — and more importantly, you are currently receiving zero treatment for your condition. An oral appliance that you actually use every night delivers infinitely more benefit than a CPAP machine that you do not use. Switching is not a step down in treatment; it is a step up from no treatment.

Frequent travelers. CPAP machines weigh two to four pounds, require a carrying case, need a power source, and must clear TSA screening. An oral appliance weighs a few ounces and fits in a toiletry bag. For people who travel frequently for work, the portability difference alone can determine whether treatment is maintained on the road.

Patients affected by the Philips recall. The Philips CPAP recall, which affected millions of devices worldwide, left many patients without a functioning machine for months or years. Many of those patients discovered oral appliances as an interim solution and never went back to CPAP.

The Market Shift: What Is Driving Billion-Dollar Growth

The oral appliance market’s projected trajectory from approximately $600 million in 2024 to over $1 billion by 2030 is driven by several converging factors that extend beyond individual patient preference.

Updated clinical guidelines. The AASM’s recognition of oral appliances as first-line therapy has opened the door for insurance coverage and physician referral patterns to shift. When the professional society endorses a treatment, the entire ecosystem — from payer reimbursement to referral networks — follows.

Insurance and access barriers for CPAP. As detailed in our coverage of Medicare’s 2026 changes, the administrative and financial barriers to CPAP therapy are increasing. Prior authorization requirements, reimbursement cuts, and supply chain issues all push patients and providers toward alternatives that bypass the insurance pathway entirely.

Consumer awareness and direct-to-consumer models. The rise of health-conscious consumers who research treatment options online before visiting a physician has expanded the OTC oral appliance market. Patients are no longer waiting for a physician to suggest alternatives — they are finding and trying oral appliances on their own, then informing their physicians about the results.

Product innovation. Modern oral appliances bear little resemblance to the rigid, one-size-fits-all jaw retainers of a decade ago. Dual-mechanism devices that combine mandibular advancement with tongue stabilization, adjustable advancement systems, and improved thermoplastic materials have made OTC devices more effective and comfortable than ever before.

How to Make the Transition

If you are considering switching from CPAP to an oral appliance, here is a practical roadmap.

Step 1: Assess your severity. If you have moderate-to-severe OSA (AHI above 15), discuss the transition with your sleep physician before stopping CPAP. For mild OSA or primary snoring, you can safely try an OTC appliance without physician approval, though informing your doctor is always good practice.

Step 2: Choose the right device. For primary snoring and mild OSA, an OTC boil-and-bite device like Snorple provides the fastest and most affordable entry point. For moderate OSA with insurance coverage, a custom dental appliance fabricated by a dental sleep specialist offers more precise adjustment. Our complete guide to stopping snoring covers the full decision framework.

Step 3: Allow an adjustment period. Most oral appliance users report a brief adjustment period of three to seven days. Mild jaw soreness and increased salivation are normal during the first week and typically resolve completely. The adaptation period is significantly shorter than the weeks many CPAP users spend trying to find a mask that works.

Step 4: Track your results. Use a sleep tracker, a snoring app, or simply ask your bed partner. If your snoring decreases significantly and you feel more rested during the day, the device is working. If you are transitioning from CPAP for diagnosed OSA, consider a follow-up sleep study after three months to confirm that your AHI is adequately controlled.

Step 5: Maintain the device. OTC oral appliances should be cleaned daily and replaced every 6 to 12 months depending on the material. Custom appliances last longer but require periodic dental check-ups to ensure fit and assess for any dental changes.

The Bottom Line

The shift from CPAP to oral appliances is not a rejection of sleep medicine — it is an evolution. CPAP remains the gold standard for severe obstructive sleep apnea and will continue to be the recommended first-line therapy for that population. But for the much larger population of primary snorers and mild-to-moderate OSA patients, the clinical evidence, real-world compliance data, and updated professional guidelines all point in the same direction: an oral appliance that you wear every night is better than a CPAP machine that you do not.

The market is responding to what patients have been saying for decades. The billion-dollar growth projection is not driven by marketing — it is driven by a fundamental realignment between treatment design and human behavior. People are more likely to use a silent, portable, comfortable device than a noisy machine with a face mask. That is not a controversial insight. It is common sense that the clinical data has finally caught up to.